Oxford BioDynamics (LSE:OBD) Long-Term Capital Lease Obligation : £5.62 Mil (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics Long-Term Capital Lease Obligation?

Oxford BioDynamics's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was £5.62 Mil.

Oxford BioDynamics's quarterly Long-Term Capital Lease Obligation declined from Sep. 2022 (£5.40 Mil) to Mar. 2023 (£5.02 Mil) but then increased from Mar. 2023 (£5.02 Mil) to Sep. 2023 (£5.62 Mil).

Oxford BioDynamics's annual Long-Term Capital Lease Obligation declined from Sep. 2021 (£5.95 Mil) to Sep. 2022 (£5.40 Mil) but then increased from Sep. 2022 (£5.40 Mil) to Sep. 2023 (£5.62 Mil).

Oxford BioDynamics Long-Term Capital Lease Obligation Historical Data

The historical data trend for Oxford BioDynamics's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Long-Term Capital Lease Obligation Chart

Oxford BioDynamics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.41

5.95

5.40

5.62

Oxford BioDynamics Semi-Annual Data
	Sep13	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial														5.95	5.75	5.40	5.02	5.62

Oxford BioDynamics (LSE:OBD) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Oxford BioDynamics Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics (LSE:OBD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

OXBOF:USA

Address

Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics (LSE:OBD) Headlines

No Headlines